Breaking News Instant updates and real-time market news.

08:25
06/29/21
06/29
08:25
06/29/21
08:25

JPMorgan alternative energy analysts hold analyst/industry conference call

US Alternative Energy Analysts Coster & Strouse and European Capital Goods Analyst Gupta provide a mid-year update for the Global Alternative Energy Industry on an Analyst/Industry conference call to be held on June 29 at 9 am.

TODAY'S FREE FLY STORIES

Periodicals
SoftBank to invest $100M in Honor Ventures, FT reports » 06:21
08/05/21
08/05
06:21
08/05/21
06:21
SFTBY

SoftBank Group

$31.15 /

+0.01 (+0.03%)

Softbank Group's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFTBY SoftBank Group
$31.15 /

+0.01 (+0.03%)

SFTBY SoftBank Group
$31.15 /

+0.01 (+0.03%)

07/21/21 JPMorgan
SoftBank Group assumed with an Overweight at JPMorgan
06/08/21 Jefferies
SoftBank upgraded to Buy from Hold at Jefferies
04/20/21 Citi
Nvidia deal for Arm has only 10% chance of closing, says Citi
03/11/21 Jefferies
SoftBank downgraded to Hold from Buy at Jefferies
SFTBY SoftBank Group
$31.15 /

+0.01 (+0.03%)

SFTBY SoftBank Group
$31.15 /

+0.01 (+0.03%)

Earnings
Core-Mark reports Q2 adjusted EPS 50c, consensus 56c » 06:20
08/05/21
08/05
06:20
08/05/21
06:20
CORE

Core-Mark

$41.11 /

-0.75 (-1.79%)

Reports Q2 revenue $4.5B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CORE Core-Mark
$41.11 /

-0.75 (-1.79%)

CORE Core-Mark
$41.11 /

-0.75 (-1.79%)

05/06/21 BMO Capital
Core-Mark price target raised to $48 from $42 at BMO Capital
03/02/21 Raymond James
Core-Mark price target raised to $42 from $34 at Raymond James
01/26/21 BMO Capital
Core-Mark upgraded to Outperform from Market Perform at BMO Capital
11/20/20 Jefferies
Core-Mark assumed with a Hold from Buy at Jefferies
CORE Core-Mark
$41.11 /

-0.75 (-1.79%)

CORE Core-Mark
$41.11 /

-0.75 (-1.79%)

Downgrade
Amedisys downgraded to Neutral from Buy at BofA » 06:20
08/05/21
08/05
06:20
08/05/21
06:20
AMED

Amedisys

/

+

BofA analyst Joanna Gajuk…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMED Amedisys
/

+

AMED Amedisys
/

+

06:03 Today BofA
Amedisys downgraded to Neutral from Buy at BofA
06/25/21 Jefferies
Medicare rule release could be catalyst for home health group, says Jefferies
05/24/21 BMO Capital
Aveanna initiated with an Outperform at BMO Capital
04/30/21 RBC Capital
Amedisys price target raised to $350 from $335 at RBC Capital
AMED Amedisys
/

+

AMED Amedisys
/

+

AMED Amedisys
/

+

Upgrade
O-I Glass upgraded to Buy from Neutral at Seaport Global » 06:20
08/05/21
08/05
06:20
08/05/21
06:20
OI

O-I Glass

$14.72 /

-0.63 (-4.10%)

Seaport Global analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OI O-I Glass
$14.72 /

-0.63 (-4.10%)

OI O-I Glass
$14.72 /

-0.63 (-4.10%)

05/20/21 Longbow
O-I Glass initiated with a Neutral at Longbow
05/03/21 Barclays
O-I Glass upgraded to Equal Weight from Underweight at Barclays
04/26/21 Baird
O-I Glass potential plan of reorganization for Paddock a positive, says Baird
02/11/21 Citi
O-I Glass price target raised to $14 from $12.50 at Citi
OI O-I Glass
$14.72 /

-0.63 (-4.10%)

Earnings
Iron Mountain narrows 2021 AFFO to $3.33 - $3.45 from $3.28-$3.45 » 06:20
08/05/21
08/05
06:20
08/05/21
06:20
IRM

Iron Mountain

$43.33 /

-0.57 (-1.30%)

Consensus for 2021 FFO is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRM Iron Mountain
$43.33 /

-0.57 (-1.30%)

IRM Iron Mountain
$43.33 /

-0.57 (-1.30%)

02/25/21 Wells Fargo
Iron Mountain price target raised to $38 from $32 at Wells Fargo
IRM Iron Mountain
$43.33 /

-0.57 (-1.30%)

IRM Iron Mountain
$43.33 /

-0.57 (-1.30%)

Periodicals
CVS stops offering J&J's Covid vaccines in pharmacies, CNBC reports » 06:20
08/05/21
08/05
06:20
08/05/21
06:20
JNJ

Johnson & Johnson

$173.35 /

-1.015 (-0.58%)

, CVS

CVS Health

$81.55 /

-2.455 (-2.92%)

, PFE

Pfizer

$45.18 /

-0.54 (-1.18%)

, BNTX

BioNTech

$414.60 /

+62.88 (+17.88%)

, MRNA

Moderna

$418.97 /

+32.18 (+8.32%)

CVS Health (CVS) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$173.35 /

-1.015 (-0.58%)

CVS CVS Health
$81.55 /

-2.455 (-2.92%)

PFE Pfizer
$45.18 /

-0.54 (-1.18%)

BNTX BioNTech
$414.60 /

+62.88 (+17.88%)

MRNA Moderna
$418.97 /

+32.18 (+8.32%)

JNJ Johnson & Johnson
$173.35 /

-1.015 (-0.58%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
07/29/21 Benchmark
Emergent BioSolutions' catalysts 'falling into place,' says Benchmark
07/08/21 Stifel
Vor Biopharma, Janssen collaboration benefits both parties, says Stifel
07/02/21 Cantor Fitzgerald
J&J vaccine shows 'strong' activist against Delta, says Cantor Fitzgerald
CVS CVS Health
$81.55 /

-2.455 (-2.92%)

07/23/21 Tigress Financial
CVS Health shares going to $108 in 12 months, says Tigress Financial
07/20/21 Cowen
CVS Health results should beat given favorable data points, says Cowen
07/08/21 Credit Suisse
Amazon Care continues with 'see what sticks' strategy, says Credit Suisse
07/02/21 Mizuho
CVS Health came out on top in PBM checks, says Mizuho
PFE Pfizer
$45.18 /

-0.54 (-1.18%)

07/30/21 Mizuho
Pfizer price target raised to $43 from $42 at Mizuho
07/26/21 Truist
Pfizer assumed with a Buy at Truist
07/26/21 Truist
Pfizer assumed with a Buy at Truist
07/23/21 BMO Capital
Arvinas price target raised to $111 from $101 at BMO Capital
BNTX BioNTech
$414.60 /

+62.88 (+17.88%)

07/19/21 Wolfe Research
BioNTech assumed with an Outperform at Wolfe Research
06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
MRNA Moderna
$418.97 /

+32.18 (+8.32%)

07/15/21 Jefferies
Moderna price target raised to $250 from $170 at Jefferies
07/07/21 Piper Sandler
Moderna could 'revolutionize' flu vaccine market, says Piper Sandler
06/29/21 Wells Fargo
Moderna vaccine demonstrates activity against key variants, says Wells Fargo
06/29/21 Goldman Sachs
Goldman continues to anticipate clinical need for booster vaccines
JNJ Johnson & Johnson
$173.35 /

-1.015 (-0.58%)

CVS CVS Health
$81.55 /

-2.455 (-2.92%)

PFE Pfizer
$45.18 /

-0.54 (-1.18%)

BNTX BioNTech
$414.60 /

+62.88 (+17.88%)

MRNA Moderna
$418.97 /

+32.18 (+8.32%)

JNJ Johnson & Johnson
$173.35 /

-1.015 (-0.58%)

CVS CVS Health
$81.55 /

-2.455 (-2.92%)

PFE Pfizer
$45.18 /

-0.54 (-1.18%)

BNTX BioNTech
$414.60 /

+62.88 (+17.88%)

MRNA Moderna
$418.97 /

+32.18 (+8.32%)

JNJ Johnson & Johnson
$173.35 /

-1.015 (-0.58%)

CVS CVS Health
$81.55 /

-2.455 (-2.92%)

PFE Pfizer
$45.18 /

-0.54 (-1.18%)

BNTX BioNTech
$414.60 /

+62.88 (+17.88%)

MRNA Moderna
$418.97 /

+32.18 (+8.32%)

JNJ Johnson & Johnson
$173.35 /

-1.015 (-0.58%)

CVS CVS Health
$81.55 /

-2.455 (-2.92%)

PFE Pfizer
$45.18 /

-0.54 (-1.18%)

BNTX BioNTech
$414.60 /

+62.88 (+17.88%)

MRNA Moderna
$418.97 /

+32.18 (+8.32%)

Recommendations
Zymeworks price target lowered to $44 from $55 at H.C. Wainwright » 06:19
08/05/21
08/05
06:19
08/05/21
06:19
ZYME

Zymeworks

$32.59 /

+0.59 (+1.84%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZYME Zymeworks
$32.59 /

+0.59 (+1.84%)

ZYME Zymeworks
$32.59 /

+0.59 (+1.84%)

03/30/21 Credit Suisse
Zymeworks initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Zymeworks initiated with an Outperform at Credit Suisse
02/25/21 SVB Leerink
Zymeworks downgraded to Market Perform at SVB Leerink
02/25/21 SVB Leerink
Zymeworks downgraded to Market Perform from Outperform at SVB Leerink
ZYME Zymeworks
$32.59 /

+0.59 (+1.84%)

Hot Stocks
Goodrich Petroleum sees 2H production 165,000-175,000 Mcfe/day in Q3 » 06:19
08/05/21
08/05
06:19
08/05/21
06:19
GDP

Goodrich Petroleum

$15.75 /

-0.55 (-3.37%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GDP Goodrich Petroleum
$15.75 /

-0.55 (-3.37%)

GDP Goodrich Petroleum
$15.75 /

-0.55 (-3.37%)

07/13/21 Roth Capital
Goodrich Petroleum price target raised to $20.50 from $13 at Roth Capital
GDP Goodrich Petroleum
$15.75 /

-0.55 (-3.37%)

Downgrade
Experian downgraded to Neutral on valuaton at Exane BNP Paribas » 06:18
08/05/21
08/05
06:18
08/05/21
06:18
EXPGY

Experian

$45.22 /

+0.38 (+0.85%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXPGY Experian
$45.22 /

+0.38 (+0.85%)

EXPGY Experian
$45.22 /

+0.38 (+0.85%)

05:08 Today Exane BNP Paribas
Experian downgraded to Neutral from Outperform at Exane BNP Paribas
07/19/21 Deutsche Bank
Experian price target raised to 2,900 GBp from 2,580 GBp at Deutsche Bank
07/19/21 RBC Capital
Experian price target raised to 2,500 GBp from 2,400 GBp at RBC Capital
06/03/21 RBC Capital
Experian downgraded to Underperform from Sector Perform at RBC Capital
Earnings
ACI Worldwide sees FY21 adjusted EBITDA $375M-$385M » 06:18
08/05/21
08/05
06:18
08/05/21
06:18
ACIW

ACI Worldwide

$32.54 /

-1.02 (-3.04%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

05/06/21 BTIG
ACI Worldwide weakness due to lack of imminent sale signals, says BTIG
02/26/21 BTIG
ACI Worldwide sale 'still appears most likely outcome,' says BTIG
12/09/20 BTIG
ACI Worldwide price target raised to $46 from $39 at BTIG
12/08/20 Craig-Hallum
ACI Worldwide price target raised to $46 from $38 at Craig-Hallum
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

Earnings
Goodrich Petroleum reports Q2 adjusted EPS 72c, consensus 50c » 06:18
08/05/21
08/05
06:18
08/05/21
06:18
GDP

Goodrich Petroleum

$15.75 /

-0.55 (-3.37%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDP Goodrich Petroleum
$15.75 /

-0.55 (-3.37%)

GDP Goodrich Petroleum
$15.75 /

-0.55 (-3.37%)

07/13/21 Roth Capital
Goodrich Petroleum price target raised to $20.50 from $13 at Roth Capital
GDP Goodrich Petroleum
$15.75 /

-0.55 (-3.37%)

Downgrade
Bunzl downgraded to Neutral on valuation at Exane BNP Paribas » 06:17
08/05/21
08/05
06:17
08/05/21
06:17
BZLFY

Bunzl

$37.16 /

-0.1 (-0.27%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BZLFY Bunzl
$37.16 /

-0.1 (-0.27%)

05:07 Today Exane BNP Paribas
Bunzl downgraded to Neutral from Outperform at Exane BNP Paribas
07/09/21 Berenberg
Bunzl upgraded to Buy from Hold at Berenberg
06/04/21 BofA
Bunzl downgraded to Neutral from Buy at BofA
04/27/21 Morgan Stanley
Bunzl downgraded to Underweight from Equal Weight at Morgan Stanley
Earnings
ACI Worldwide sees Q3 revenue $310M-$320M, consensus $331.72M » 06:17
08/05/21
08/05
06:17
08/05/21
06:17
ACIW

ACI Worldwide

$32.54 /

-1.02 (-3.04%)

Sees Q3 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

05/06/21 BTIG
ACI Worldwide weakness due to lack of imminent sale signals, says BTIG
02/26/21 BTIG
ACI Worldwide sale 'still appears most likely outcome,' says BTIG
12/09/20 BTIG
ACI Worldwide price target raised to $46 from $39 at BTIG
12/08/20 Craig-Hallum
ACI Worldwide price target raised to $46 from $38 at Craig-Hallum
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

Earnings
Iron Mountain reports Q2 AFFO 85c, consensus 64c » 06:17
08/05/21
08/05
06:17
08/05/21
06:17
IRM

Iron Mountain

$43.33 /

-0.57 (-1.30%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRM Iron Mountain
$43.33 /

-0.57 (-1.30%)

IRM Iron Mountain
$43.33 /

-0.57 (-1.30%)

02/25/21 Wells Fargo
Iron Mountain price target raised to $38 from $32 at Wells Fargo
IRM Iron Mountain
$43.33 /

-0.57 (-1.30%)

IRM Iron Mountain
$43.33 /

-0.57 (-1.30%)

Downgrade
Venator Materials downgraded to Neutral from Buy at BofA » 06:16
08/05/21
08/05
06:16
08/05/21
06:16
VNTR

Venator Materials

$3.15 /

-0.18 (-5.41%)

, TROX

Tronox

$17.81 /

-0.47 (-2.57%)

, CC

Chemours

$32.69 /

-1.45 (-4.25%)

BofA analyst Matthew …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TROX Tronox
$17.81 /

-0.47 (-2.57%)

CC Chemours
$32.69 /

-1.45 (-4.25%)

VNTR Venator Materials
$3.15 /

-0.18 (-5.41%)

06:02 Today BofA
Venator Materials downgraded to Neutral from Buy at BofA
08/04/21 Citi
Venator Materials price target lowered to $3.70 from $4.50 at Citi
02/25/21 Deutsche Bank
Venator Materials price target raised to $5.50 from $3 at Deutsche Bank
11/30/20 BofA
Venator Materials upgraded to Buy from Underperform at BofA
TROX Tronox
$17.81 /

-0.47 (-2.57%)

05/20/21
Fly Intel: Top five analyst initiations
05/20/21 BofA
BofA starts Tronox at Buy with $28 price target
05/20/21 BofA
Tronox initiated with a Buy at BofA
12/28/20 Alembic Global
Dow Inc., Olin, Tronox named among 2021 chemical top picks at Alembic Global
CC Chemours
$32.69 /

-1.45 (-4.25%)

08/03/21 RBC Capital
Chemours price target raised to $40 from $35 at RBC Capital
06/30/21 BMO Capital
Chemours price target raised to $48 from $42 at BMO Capital
06/09/21 Wolfe Research
Chemours initiated with an Outperform at Wolfe Research
06/09/21
Fly Intel: Top five analyst upgrades
VNTR Venator Materials
$3.15 /

-0.18 (-5.41%)

TROX Tronox
$17.81 /

-0.47 (-2.57%)

CC Chemours
$32.69 /

-1.45 (-4.25%)

  • 25
    Feb
TROX Tronox
$17.81 /

-0.47 (-2.57%)

CC Chemours
$32.69 /

-1.45 (-4.25%)

Recommendations
Mayville Engineering poised for growth in 2022, says Baird » 06:16
08/05/21
08/05
06:16
08/05/21
06:16
MEC

Mayville Engineering

$16.90 /

-0.63 (-3.59%)

Baird analyst Mircea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEC Mayville Engineering
$16.90 /

-0.63 (-3.59%)

MEC Mayville Engineering
$16.90 /

-0.63 (-3.59%)

06/25/21 Citi
Citi has 'increased conviction' in Mayville after management meetings
04/08/21 Baird
Mayville Engineering strategic customer adds to growth potential, says Baird
03/03/21 Baird
Mayville Engineering results suggest volume recovery continues, says Baird
02/04/21 Baird
Mayville Engineering price target raised to $20 from $14 at Baird
MEC Mayville Engineering
$16.90 /

-0.63 (-3.59%)

Earnings
ACI Worldwide reports Q2 EPS 6c, consensus 8c » 06:15
08/05/21
08/05
06:15
08/05/21
06:15
ACIW

ACI Worldwide

$32.54 /

-1.02 (-3.04%)

Reports Q2 revenue $302M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

05/06/21 BTIG
ACI Worldwide weakness due to lack of imminent sale signals, says BTIG
02/26/21 BTIG
ACI Worldwide sale 'still appears most likely outcome,' says BTIG
12/09/20 BTIG
ACI Worldwide price target raised to $46 from $39 at BTIG
12/08/20 Craig-Hallum
ACI Worldwide price target raised to $46 from $38 at Craig-Hallum
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

Earnings
Wesco raises FY21 adjusted EPS view to $8.40-$8.80 from $6.80-$7.30 » 06:14
08/05/21
08/05
06:14
08/05/21
06:14
WCC

Wesco

$105.89 /

-2.01 (-1.86%)

FY21 consensus $7.22.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WCC Wesco
$105.89 /

-2.01 (-1.86%)

WCC Wesco
$105.89 /

-2.01 (-1.86%)

08/03/21 Loop Capital
Wesco initiated with a Buy at Loop Capital
05/11/21 KeyBanc
Wesco price target raised to $125 from $96 at KeyBanc
05/10/21 Oppenheimer
Wesco price target raised to $125 from $90 at Oppenheimer
05/07/21 RBC Capital
Wesco price target raised to $119 from $109 at RBC Capital
WCC Wesco
$105.89 /

-2.01 (-1.86%)

WCC Wesco
$105.89 /

-2.01 (-1.86%)

Earnings
Walker & Dunlop reports Q2 EPS $1.73, consensus $2.04 » 06:14
08/05/21
08/05
06:14
08/05/21
06:14
WD

Walker & Dunlop

$102.76 /

+1.245 (+1.23%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WD Walker & Dunlop
$102.76 /

+1.245 (+1.23%)

WD Walker & Dunlop
$102.76 /

+1.245 (+1.23%)

06/14/21 Wolfe Research
Walker & Dunlop initiated with an Outperform at Wolfe Research
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
02/10/21 Wedbush
Walker & Dunlop price target raised to $112 from $98 at Wedbush
02/05/21 Keefe Bruyette
Walker & Dunlop price target raised to $90 from $85 at Keefe Bruyette
WD Walker & Dunlop
$102.76 /

+1.245 (+1.23%)

WD Walker & Dunlop
$102.76 /

+1.245 (+1.23%)

Recommendations
Ortho Clinical Diagnostics price target raised to $30 from $27 at H.C. Wainwright » 06:14
08/05/21
08/05
06:14
08/05/21
06:14
OCDX

Ortho Clinical Diagnostics

$21.81 /

+0.19 (+0.88%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCDX Ortho Clinical Diagnostics
$21.81 /

+0.19 (+0.88%)

OCDX Ortho Clinical Diagnostics
$21.81 /

+0.19 (+0.88%)

08/04/21 Credit Suisse
Ortho Clinical Diagnostics assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Ortho Clinical Diagnostics price target raised to $27 from $24 at Barclays
03/02/21 Barclays
Ortho Clinical Diagnostics initiated with an Overweight at Barclays
03/02/21 Barclays
Ortho Clinical Diagnostics initiated with an Overweight at Barclays
OCDX Ortho Clinical Diagnostics
$21.81 /

+0.19 (+0.88%)

  • 28
    Jan
OCDX Ortho Clinical Diagnostics
$21.81 /

+0.19 (+0.88%)

Recommendations
Dynavax price target raised to $20 from $16 at H.C. Wainwright » 06:13
08/05/21
08/05
06:13
08/05/21
06:13
DVAX

Dynavax

$9.88 /

+0.14 (+1.44%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DVAX Dynavax
$9.88 /

+0.14 (+1.44%)

DVAX Dynavax
$9.88 /

+0.14 (+1.44%)

02/08/21 Evercore ISI
Dynavax had 'big vaccine update week,' says Evercore ISI
02/01/21 Cowen
Dynavax undervalued for potential of Heplisav and COVID vaccine, says Cowen
02/01/21 H.C. Wainwright
Dynavax price target raised to $15 from $14 at H.C. Wainwright
11/06/20 H.C. Wainwright
Dynavax price target raised to $14 from $12 at H.C. Wainwright
DVAX Dynavax
$9.88 /

+0.14 (+1.44%)

DVAX Dynavax
$9.88 /

+0.14 (+1.44%)

DVAX Dynavax
$9.88 /

+0.14 (+1.44%)

Earnings
MultiPlan raises 2021 revenue view to $1.09B-$1.13B from $1.04B-$1.10B » 06:13
08/05/21
08/05
06:13
08/05/21
06:13
MPLN

MultiPlan

$7.72 /

-0.045 (-0.58%)

Consensus for FY21…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

07/07/21 Citi
Citi sees policy change being narrowly applied, keeps Buy on MultiPlan
05/14/21 B. Riley
MultiPlan quarter highlights industry positioning, says B. Riley
04/07/21 B. Riley
B. Riley starts MultiPlan at Buy, sees 'meaningful investment opportunity'
04/06/21 B. Riley
MultiPlan initiated with a Buy at B. Riley
MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

Recommendations
Astec production improvements needed to improve sentiment, says Baird » 06:13
08/05/21
08/05
06:13
08/05/21
06:13
ASTE

Astec

$59.54 /

-1.46 (-2.39%)

Baird analyst Mircea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASTE Astec
$59.54 /

-1.46 (-2.39%)

ASTE Astec
$59.54 /

-1.46 (-2.39%)

05/18/21 Baird
Astec capital deployment a potential catalyst, says Baird
05/06/21 Stifel
Astec upgraded to Buy at Stifel on 'encouraging' backlog and order trends
05/06/21 Stifel
Astec upgraded to Buy from Hold at Stifel
03/01/21 Baird
Astec price target raised to $92 from $90 at Baird
ASTE Astec
$59.54 /

-1.46 (-2.39%)

ASTE Astec
$59.54 /

-1.46 (-2.39%)

Recommendations
Clovis price target lowered to $10 from $12 at H.C. Wainwright » 06:13
08/05/21
08/05
06:13
08/05/21
06:13
CLVS

Clovis

$4.81 /

-0.04 (-0.82%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLVS Clovis
$4.81 /

-0.04 (-0.82%)

CLVS Clovis
$4.81 /

-0.04 (-0.82%)

06/07/21 Piper Sandler
Clovis reported 'underwhelming datasets' at ASCO, says Piper Sandler
03/19/21 Goldman Sachs
Goldman says Clovis reaction 'disproportionate' for already disclosed data
02/23/21 H.C. Wainwright
Clovis price target lowered to $13 from $15 at H.C. Wainwright
02/23/21 Piper Sandler
Clovis price target raised to $5.75 from $5.00 at Piper Sandler
CLVS Clovis
$4.81 /

-0.04 (-0.82%)

CLVS Clovis
$4.81 /

-0.04 (-0.82%)

CLVS Clovis
$4.81 /

-0.04 (-0.82%)

Earnings
Wesco reports Q2 adjusted EPS $2.64, consensus $1.90 » 06:12
08/05/21
08/05
06:12
08/05/21
06:12
WCC

Wesco

$105.89 /

-2.01 (-1.86%)

Reports Q2 revenue $4.6B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WCC Wesco
$105.89 /

-2.01 (-1.86%)

WCC Wesco
$105.89 /

-2.01 (-1.86%)

08/03/21 Loop Capital
Wesco initiated with a Buy at Loop Capital
05/11/21 KeyBanc
Wesco price target raised to $125 from $96 at KeyBanc
05/10/21 Oppenheimer
Wesco price target raised to $125 from $90 at Oppenheimer
05/07/21 RBC Capital
Wesco price target raised to $119 from $109 at RBC Capital
WCC Wesco
$105.89 /

-2.01 (-1.86%)

WCC Wesco
$105.89 /

-2.01 (-1.86%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.